RIO DE JANEIRO: Pfizer Inc has delivered the results of the Phase 3 trial for its COVID-19 vaccine to Brazilian health regulator Anvisa, the regulatory body said in a statement on Wednesday.

Pfizer is the second company to do so after AstraZeneca Plc delivered its results to Anvisa earlier in December.